Aspartylglycosamine is a biomarker for NGLY1-CDDG, a congenital disorder of deglycosylation

Hanneke A. Haijes*, Monique G.M. de Sain-van der Velden, Hubertus C.M.T. Prinsen, Anke P. Willems, Maria van der Ham, Johan Gerrits, Madeline H. Couse, Jan M. Friedman, Clara D.M. van Karnebeek, Kathryn A. Selby, Peter M. van Hasselt, Nanda M. Verhoeven-Duif, Judith J.M. Jans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Aspartylglycosamine is a biomarker for NGLY1-CDDG, a congenital disorder of deglycosylation'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry